Lung Disease

Respiratory·MeSH: Lung Diseases

29 drugs in development·21 companies·2 clinical trials

Drug Pipeline by Phase

Approved(10)

Drug	Company
etorel	GYRE THERAPEUTICS, INC. (GYRE)
nintedanib	X4 Pharmaceuticals, Inc (XFOR)
nintedanib	NYMOX PHARMACEUTICAL CORP (NYMXF)
nintedanib	GYRE THERAPEUTICS, INC. (GYRE)
nintedanib	EXELIXIS, INC. (EXEL)
nintedanib	DR REDDYS LABORATORIES LTD (RDY)
nintedanib	Aptinyx Inc. (APTX)
theophylline	Amneal Pharmaceuticals, Inc. (AMRX)
tyvaso dpi	MANNKIND CORP (MNKD)
YUTREPIA	Liquidia Corp (LQDA)

Phase 3(6)

Drug	Company
alvelestat	Mereo BioPharma Group plc (MREO)
clofazimine inhalation	MANNKIND CORP (MNKD)
hec585 dose a	SUNSHINE BIOPHARMA INC. (SBFM)
hec585 dose b	SUNSHINE BIOPHARMA INC. (SBFM)
L606	Liquidia Corp (LQDA)
Nerandomilast	Valneva SE (VALN)

Phase 2(4)

Drug	Company
INS1148	INSMED Inc (INSM)
L-menthol	Crinetics Pharmaceuticals, Inc. (CRNX)
mosliciguat	Roivant Sciences Ltd. (ROIV)
tx45	Tectonic Therapeutic, Inc. (TECX)

Phase 1(1)

Drug	Company
ace-1334	ACCELERON PHARMA INC (XLRN)

Preclinical(2)

Drug	Company
4D-725	4D Molecular Therapeutics, Inc. (FDMT)
eq504	Equillium, Inc. (EQ)

Phase 2/Phase 3(4)

Drug	Company
bedaquiline	NYMOX PHARMACEUTICAL CORP (NYMXF)
Epetraborole	AN2 Therapeutics, Inc. (ANTX)
ethambutol	NYMOX PHARMACEUTICAL CORP (NYMXF)
rifampicin	NYMOX PHARMACEUTICAL CORP (NYMXF)

Phase 4(2)

Drug	Company
telitacicept	GH Research PLC (GHRS)
tocilizumab	GH Research PLC (GHRS)

BioSniper tracks 29 drugs in development for Lung Disease across 21 companies.

There are 2 clinical trials targeting Lung Disease tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.